ASOA Gold Partner - Alcon iLUX

Over 30 million people in the US suffer from dry eye. 86% of dry eye patients have signs of MGD. The Systane® iLux® suite of three innovations embrace Alcon's dry eye suite to have the tools you need to help tackle MGD from start to finish.

The Systane® iLux® MGD Thermal Pulsation System delivers treatment directly to the blocked meibomian glands with the goal of clearing any obstructions. Treatment of both eyes takes approximately 8–12 minutes.